Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites-Reference-Cited by-同舟云学术

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites

Published:2011-03-15 Issue:2 Volume:17 Page:223-233
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Brouwers N,Van Cauwenberghe C,Engelborghs S,Lambert J-C,Bettens K,Le Bastard N,Pasquier F,Montoya A Gil,Peeters K,Mattheijssens M,Vandenberghe R,De Deyn P P,Cruts M,Amouyel P,Sleegers K,Van Broeckhoven C

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/mp201124.pdf

Reference38 articles.

1. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41: 1088–1093.

2. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41: 1094–1099.

3. Krych-Goldberg M, Atkinson JP . Structure-function relationships of complement receptor type 1. Immunol Rev 2001; 180: 112–122.

4. Khera R, Das N . Complement receptor 1: disease associations and therapeutic implications. Mol Immunol 2009; 46: 761–772.

5. Dykman TR, Cole JL, Iida K, Atkinson JP . Polymorphism of human erythrocyte C3b/C4b receptor. Proc Natl Acad Sci USA 1983; 80: 1698–1702.

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential effect of an evolving amyloid and tau pathology on brain phospholipids and bioactive lipid mediators in rat models of Alzheimer-like pathology;Journal of Neuroinflammation;2024-07-30

2. A Specialized Reference Panel with Structural Variants Integration for Improving Genotype Imputation in Alzheimer’s Disease and Related Dementias (ADRD);2024-07-23

3. Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies;Biomolecules;2024-07-11

4. Cerebral amyloid angiopathy and the immune system;Alzheimer's & Dementia;2024-06-17

5. Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches;International Journal of Molecular Sciences;2024-02-15